Benzinga | Mar 17, 2021 07:32AM EDT

Codiak BioSciences Q4 EPS $(1.14) Beats $(1.54) Estimate, Sales $1.64M Up From $150.00K YoY

Codiak BioSciences (NASDAQ:CDAK) reported quarterly losses of $(1.14) per share which beat the analyst consensus estimate of $(1.54) by 25.97 percent. The company reported $1.64 million in sales this quarter. This is a 992.67 percent increase over sales of $150.00 thousand the same period last year.